OBJECTIVE: To study the effect of healthcare access and other characteristics on physician trust among black and white prostate cancer patients. METHODS: A three-timepoint follow-up telephone survey after cancer diagnosis was conducted. This study analyzed data on 474 patients and their 1,320 interviews over three time periods. RESULTS: Among other subpopulations, black patients who delayed seeking care had physician trust levels that were far lower than that of both Caucasians as well as that of the black patients overall. Black patients had greater variability in their levels of physician trust compared to their white counterparts. CONCLUSIONS: Both race and access are important in explaining overall lower levels and greater variability in physician trust among black prostate cancer patients. Access barriers among black patients may spill over to the clinical encounter in the form of less physician trust, potentially contributing to racial disparities in treatment received and subsequent outcomes. Policy efforts to address the racial disparities in prostate cancer should prioritize improving healthcare access among minority groups.
OBJECTIVE: To study the effect of healthcare access and other characteristics on physician trust among black and white prostate cancerpatients. METHODS: A three-timepoint follow-up telephone survey after cancer diagnosis was conducted. This study analyzed data on 474 patients and their 1,320 interviews over three time periods. RESULTS: Among other subpopulations, black patients who delayed seeking care had physician trust levels that were far lower than that of both Caucasians as well as that of the black patients overall. Black patients had greater variability in their levels of physician trust compared to their white counterparts. CONCLUSIONS: Both race and access are important in explaining overall lower levels and greater variability in physician trust among black prostate cancerpatients. Access barriers among black patients may spill over to the clinical encounter in the form of less physician trust, potentially contributing to racial disparities in treatment received and subsequent outcomes. Policy efforts to address the racial disparities in prostate cancer should prioritize improving healthcare access among minority groups.
Authors: Vickie L Shavers; Martin L Brown; Arnold L Potosky; Carrie N Klabunde; W W Davis; Judd W Moul; Angela Fahey Journal: J Gen Intern Med Date: 2004-02 Impact factor: 5.128
Authors: Vickie L Shavers; Martin Brown; Carrie N Klabunde; Arnold L Potosky; William Davis; Judd Moul; Angela Fahey Journal: Med Care Date: 2004-03 Impact factor: 2.983
Authors: Adam B Murphy; Ramona Bhatia; Iman K Martin; David A Klein; Courtney M P Hollowell; Yaw Nyame; Elodi Dielubanza; Chad Achenbach; Rick A Kittles Journal: Cancer Epidemiol Biomarkers Prev Date: 2014-07-25 Impact factor: 4.254
Authors: Nicole C Wright; Mary E Melton; Maira Sohail; Ivan Herbey; Susan Davies; Emily B Levitan; Kenneth G Saag; Natalia V Ivankova Journal: J Racial Ethn Health Disparities Date: 2019-02-11
Authors: Sarah E Choi; Quyen Ngo-Metzger; John Billimek; Sheldon Greenfield; Sherrie H Kaplan; Dara H Sorkin Journal: J Immigr Minor Health Date: 2016-04